Science Explorer Back to mapMap
Discussion
Researcher · Novartis (Switzerland) · Switzerland

Stéphanie Deudon

Stéphanie Deudon publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Advanced Breast Cancer Therapies.

OpenAlex
World rank
#2,493,051
of 7,710,434 ranked researchers
Rank in Switzerland
#38,328
of 80,918
Works
26
Citations
1.2k
Citations per work
44.8
h-index
6
i10-index 6Top 78% in Pulmonary and Respiratory Medicine
Stéphanie Deudon

What does Stéphanie Deudon research?

Stéphanie Deudon's work is mostly in Medicine (75%), Biochemistry, Genetics and Molecular Biology (20%).

Health Sciences: 20 works · 75.0% of their workMedicine: 20 works · 75.0% of their workPulmonary and Respiratory Medicine: 10 works · 38.3% of their workOncology: 10 works · 36.7% of their workLife Sciences: 5 works · 19.9% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 19.9% of their workMolecular Biology: 2 works · 8.3% of their workCancer Research: 1 works · 5.0% of their workCell Biology: 1 works · 3.3% of their workGenetics: 1 works · 3.3% of their workEverything else: 1 works · 5.1% of their workTHEIR WORKStéphanie Deudon26works
Life Sciences20%Health Sciences75%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2075.0%
    1. Biochemistry, Genetics and Molecular Biology519.9%
  3. Everything else15.1%
  1. 1Pulmonary and Respiratory Medicine38% of their works
  2. 2Oncology37% of their works
  3. 3Molecular Biology8% of their works
  4. 4Cancer Research5% of their works
  5. 5Genetics3% of their works
  6. 6Cell Biology3% of their works

Research topics

Which keywords describe Stéphanie Deudon's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Breast Cancer, ALK Inhibitors, EGFR Mutations, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Clinical Trials142 topics
  2. Targeted Therapy142 topics
  3. Chemotherapy123 topics
  4. Breast Cancer112 topics
  5. ALK Inhibitors101 topic
  6. EGFR Mutations101 topic
  7. Immune Checkpoint Blockade91 topic
  8. PD-1 and PD-L191 topic
  9. CDK4/6 Inhibitors71 topic
  10. Palbociclib71 topic
  11. Radiotherapy62 topics
  12. CT Screening41 topic
  13. FGF2141 topic
  14. Fibroblast Growth Factor41 topic
  15. Genomic Profiles41 topic
  16. HER241 topic
  17. Lung Cancer41 topic
  18. Small-Cell Lung Cancer41 topic
  19. Trastuzumab41 topic
  20. Breast Tumours21 topic
  21. Gene Expression21 topic

Where does Stéphanie Deudon work?

Stéphanie Deudon's main affiliation in the publication record is Novartis (Switzerland), Switzerland.

How many publications and citations does Stéphanie Deudon have?

OpenAlex counts 26 works and 1,164 citations for Stéphanie Deudon, an h-index of 6, ranking #2,493,051 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stéphanie Deudon. Posts are plain text and can be reported.